Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up
This study is not yet open for participant recruitment.
Verified by Group Health Cooperative, June 2008
Sponsors and Collaborators: Group Health Cooperative
Kaiser Permanente
Fred Hutchinson Cancer Research Center
Information provided by: Group Health Cooperative
ClinicalTrials.gov Identifier: NCT00697047
  Purpose

SOS is a four-arm randomized controlled study of ways to increase screening for colonrectal cancer. About 40-50% of the people age 50 and older are not up to date on screening. This is a very important problem because screening both prevents colorectal cancer and decreases colon cancer deaths.

We are studying 3 different levels of support to help people get screened and follow-up after positive screening tests. These involve comparing to usual care stepwise increasing in intensity approaches; an automated approach of mailing information and home screening tests, this plus phone assistance by a medical assistant, both of these plus phone counseling and care management. We will also compare nurse assisted follow-up after a positive screening test compared to usual care

By doing this study we hope to increase colon cancer screening rates, and also follow-up rates for positive screening tests.


Condition Intervention
Colorectal Cancer Screening
Behavioral: Usual care plus automated mailing
Behavioral: Usual care, automated mailing plus phone assistance by a medical assistant
Behavioral: Usual care, automated mailing, phone assistance by a medical assistant, who refers care to a registered nurse who provides care management for screening

MedlinePlus related topics: Cancer Colorectal Cancer
U.S. FDA Resources
Study Type: Interventional
Study Design: Screening, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Systems of Support to Increase Colon Cancer Screening and Follow-up

Further study details as provided by Group Health Cooperative:

Primary Outcome Measures:
  • Colorectal cancer screening rates (as defined by both the NCQA HEDIS measure and the American Cancer Society), and follow-up rates after a positive screening test. [ Time Frame: Baseline, 12 mo f/u, 24 mo f/u, and 6mo after positive screening test ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Cognitive, affective, and social factors related to CRCS, satisfaction with medical services, utilization and costs. [ Time Frame: Baseline, 24 mo f/u, and 6mo after positive screening test ] [ Designated as safety issue: No ]

Estimated Enrollment: 6200
Study Start Date: July 2008
Estimated Study Completion Date: May 2012
Estimated Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: No Intervention
Usual Care
2: Experimental
Usual care plus automated mailing
Behavioral: Usual care plus automated mailing
Part 2 - patients with positive stool test or flexible sigmoidoscopy are randomized to receive usual care or nurse care management (registered nurse)
3: Experimental
Usual care, automated mailing plus phone assistance by a medical assistant who helps patients clarify screening intent and refers care (such as ordering a screening colonoscopy) back to the patient's physician.
Behavioral: Usual care, automated mailing plus phone assistance by a medical assistant
Part 2 - patients with positive stool test or flexible sigmoidoscopy are randomized to receive usual care or nurse care management (registered nurse)
4: Experimental
Usual care, automated mailing, phone assistance by a medical assistant, who refers care to a registered nurse who provides care management for screening (assesses risks related to screening tests, counsels and assists patient in making a screening choice, and arranges the screening plan).
Behavioral: Usual care, automated mailing, phone assistance by a medical assistant, who refers care to a registered nurse who provides care management for screening
Part 2 - patients with positive stool test or flexible sigmoidoscopy are randomized to receive usual care or nurse care management (registered nurse)

Detailed Description:

Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up A. Specific Aims There is strong evidence that colorectal cancer screening (CRCS) decreases colorectal cancer (CRC) mortality and reduces colorectal cancer incidence. Despite the efficacy of screening, 40-60% of eligible adults are not screened at recommended intervals, and many have never had any type of CRCS. Screening failures occur not only from lack of screening but also from breakdowns in follow-up of positive tests, which obviates the benefits of screening. Strategies for improving the uptake of CRCS typically focus on either patients or health care providers, without describing the infrastructure changes, or systems of support (SOS), that are required to implement and sustain these changes.

We propose a two-part study using the Chronic Care Model to organize SOS. We will identify a cohort of Group Health patients aged 50 -73 years who have not had a colonoscopy (CS) in 10 years, a flexible sigmoidoscopy (FS) in 5 years, or a fecal occult blood test (FOBT) in 10 months.

Part One:

Subjects will be randomized to receive one of four interventions of stepwise increasing intensity of support.

  1. Usual care (UC).
  2. Automated (UC+ mailed information, access to a cancer screening hotline, mailed FOBT cards, and a reminder card).
  3. Assisted (UC + automated + a medical assistant) to document screening intent and assists patients via the resources already supplied or sending requests to the patient's physician.
  4. Care management (UC + automated + assisted + cancer screening nurse support) who counsels patient and assists with this screening plan (assessing procedural risk, and ordering tests).

Part Two: Patients with a positive FOBT or a positive FS (CS needed) will be randomized to one of two follow-up intervention arms: A. Usual care (which at Group Health includes a registry and physician alerts) or B. Care Management (UC + cancer screening nurse who manages care after a positive test). Our study hypotheses are that increasing levels of SOS will result in increasing CRCS rates, and care management by cancer screening nurses will increase follow-up rates after a positive test.

The primary specific aims are:

  1. To compare the effectiveness of each intervention condition on increasing CRCS rates.
  2. To compare the effectiveness of each intervention condition on follow-up after a positive screening test.

    The secondary aims are:

  3. To assess the effects of each intervention condition on participants' cognitive, affective, and social factors related to CRCS adherence and satisfaction with medical services
  4. To compare utilization, costs, and incremental cost-effectiveness of each intervention condition.
  Eligibility

Ages Eligible for Study:   50 Years to 73 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Not up to date on CRCS
  • Continuously enrolled in GHC for 24 months
  • Expected to continue to be enrolled at GHC for 24 months.

Exclusion Criteria:

  • Known high risk for CRC
  • History of CRC
  • History of inflammatory bowel disease
  • Current anticoagulation therapy
  • Organ failure
  • Serious illness
  • Debilitating disease
  • Dementia
  • Nursing home resident.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00697047

Contacts
Contact: Lynda T Tyll, RN, MS 206-287-2939 tyll.l@ghc.org
Contact: Beverly B Green, MY, MPH 206-287-2997 green.b@ghc.org

Locations
United States, Washington
Group Health Cooperative -Center for Health Studies
Seattle, Washington, United States, 98101
Sponsors and Collaborators
Group Health Cooperative
Kaiser Permanente
Fred Hutchinson Cancer Research Center
Investigators
Principal Investigator: Beverly B Green, MD, MPH Group Health Cooperative
  More Information

Responsible Party: Group Health Cooperative, Center for Health Studies ( Beverly B. Green, MD, MPH (Principal Investigator) )
Study ID Numbers: 5RO1CA121125, CFDA: 93.393, OC: 414E, PCC:4KHE
Study First Received: June 11, 2008
Last Updated: June 12, 2008
ClinicalTrials.gov Identifier: NCT00697047  
Health Authority: United States: Institutional Review Board

Keywords provided by Group Health Cooperative:
Colorectal Neoplasms
Mass Screening
Population Surveillance
Randomized controlled trial
Occult Blood
Colonoscopy
Sigmoidoscopy
Health Behavior

Study placed in the following topic categories:
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Colonic Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Rectal Diseases
Colonic Neoplasms
Intestinal Neoplasms
Colorectal Neoplasms

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 15, 2009